Retrospective electronic medical record review was used to determine outcomes before and after QI activities in a multispecialty ambulatory clinic of a tertiary care Veterans Affairs facility and its affi liated satellite clinics. From 1869 FOBT-positive cases, 800 were randomly selected from time periods before and after QI activities. Two reviewers used a pretested standardized data collection form to determine whether colonoscopy was appropriate or indicated based on predetermined criteria and if so, the timeliness of colonoscopy referral and performance before and after QI activities.
INTRODUCTION
Many studies that address follow-up of abnormal cancer screening examinations reveal that fewer than 75 % of patients receive diagnostic care subsequent to the initial screening (1 -5) . Because colorectal cancer (CRC) is the second leading cause of cancer death in the United States, bene ts of population-based screening programs may be considerably compromised by inadequate follow-up of abnormal screens (6 -9) . For instance, high-sensitivity fecal occult blood test (FOBT) using the Hemoccult SENSA method is the dominant mode of screening for CRC in the Department of Veterans A airs (VA) (10) , but more than 40 % of veterans with a positive FOBT may not be receiving timely follow-up with colonoscopies (11) . Inadequate follow-up of abnormal FOBT has been also documented in other types of practice settings (1,2,6,12 -15) .
Inadequate FOBT follow-up may be related to patient-level, provider-level, or system-level factors (1,2,16 -18) . In some health care systems including the VA, signi cant barriers to adequate follow-up may exist, including limited endoscopic capacity (endoscopists, support sta rooms, and equipment) and limited resources for obtaining timely followup diagnostic procedures (16) . Delays may also arise from problems in having patients complete the scheduled colonoscopy procedure (post-colonoscopy referral delays) (1, 19) . However, an important and largely preventable determinant of system-level delay is a problem in communication of the abnormal FOBT result from the laboratory to providers who ordered them (20,20 -22) .
is may be due to lack of transmission of the test result or from inaction on the results by ordering providers (pre-colonoscopy referral delays) (2, 14, 18, 23) .
Given the multifactorial origin of preventable delays, the primary care and gastroenterology (GI) sections in our VA implemented quality improvement (QI) activities in 2004 -2005 to improve follow-up care for FOBT-positive results.
ese activities addressed many pre-colonoscopy referral processes and targeted system-level factors such as communication (24) , provider education, and feedback. ey were speci cally chosen because of their feasibility and relative ease of implementation. Some of the QI activities were promoted by a VA CRC Quality Enhancement Research Initiative with a mission to " promote the implementation of CRC-related research discoveries and evidence-based care " among veterans. is initiative -the CRC Care Collaborative (C4) -emphasizes the need to reduce the time from positive screening test to diagnostic test and was fostered by partnerships among the CRC Quality Enhancement Research Initiative, VA O ce of Quality and Performance, and VA Advanced Clinic Access.
In this study, we aimed to evaluate the e ects of implementation of these QI activities on the timeliness and appropriateness of follow-up for positive FOBT results with a colonoscopy and to identify factors that a ect colonoscopy performance.
METHODS

Setting
We studied outcomes pre-and post-QI activities at the multispecialty ambulatory clinic of the Michael E. DeBakey Veterans A airs Medical Center in Houston, TX, and its a liated satellite clinics. More than half of the CRC screening eligible patient population relies on annual FOBT using the Hemoccult SENSA method as the dominant mode of screening. e study was approved by the Baylor College of Medicine Institutional Review Board and the Michael E. DeBakey Veterans A airs Medical Center Research and Development Committee.
QI initiatives
During calendar years 2004 -2005, our institution launched a multifaceted QI e ort to improve FOBT follow-up. First, pdf copies of CRC screening guidelines that were recently released at the time (25) were disseminated to all primary care providers (PCPs) through electronic mail (e-mail) and a memorandum with summary of the guidelines was sent to the PCPs through their supervisor. Second, the GI service took measures to reduce colonoscopy backlog. e GI service assigned a dedicated allied health provider to process electronic consultations on a near-full time basis. It also made e orts to decrease the number of consultations received (especially unnecessary consultations) through two educational strategies: lectures to PCPs including residents rotating through the clinic and development and e-mail dissemination of an FOBT follow-up algorithm. Both these activities were geared to reduce backlog and waiting time for GI consults. For instance, activities emphasized the use of annual home-based FOBT as the main tool for screening for low-or average-risk patients in lieu of screening colonoscopy, provided information on appropriateness of screening techniques, and agging urgent consultations. ird, our institution put into place several standard operating procedures regarding an electronic FOBT result noti cation system. e VA uses an advanced electronic medical record (EMR)-based noti cation system (the View Alert system) that immediately alerts clinicians about clinically signi cant events such as critically abnormal test results. Our institution implemented a policy through which every positive FOBT result was categorized as " critical " and hence was sent as a mandatory alert noti cation to the ordering provider and at times a back-up provider (such as the faculty supervisor of a resident trainee). All providers ( ~ 50 PCPs) received alerts on their patient ' s positive FOBT results and were expected to read them to initiate follow-up. Hence, this policy ensured mandatory noti cation to providers and reduced potential breakdowns in communication between the laboratory and the clinicians. Fourth, to augment the electronic communication through the EMR, an additional noti cation strategy was pursued. e preventive medicine coordinator, who is responsible for tracking VA performance measures, used a laboratory soware program to identify all FOBT-positive results and notied the patient ' s PCP through a paper noti cation in their mail box (this occurred in each case in addition to the EMR alert).
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e notice was sent to all PCPs whose patients had positive FOBT. Fi h, the coordinator regularly tracked the FOBT-positive cases for follow-up actions such as response by the PCP and colonoscopy performance. For instance, if no documentation of follow-up action by the provider (such as colonoscopy consultation, documentation of patient refusal of test, etc.) was noted for more than 2 weeks a er the test, a second notice was sent to the PCP. Similarly, a er a colonoscopy was requested, the coordinator tracked if an appointment was given. If not, paper copies of the consultation were sent on a monthly basis to one of the gastroenterologists for action. e coordinator then tracked patients to their colonoscopy appointments by maintaining a list of all the FOBT-positive patients in a Microso Excel database. If patients canceled or failed to show up for their appointments or for some reason the procedure was canceled, providers were informed again through written notices. In addition to his usual job responsibilities of performance measurement reporting, the coordinator was able to dedicate ~ 4 hours in a week to these tasks.
Data collection
Inclusion / exclusion criteria . We identi ed all FOBT-positive tests through a standardized laboratory extraction tool soware program used by the VA system in a 12-month period pre-and post-QI implementation. From 1,117 cases of positive FOBTs in the pre-implementation phase from January 1, 2003 to December 31, 2003, we used computer generated randomization scheme to select 401 cases for review (a case was de ned as one or more positive FOBT). Similarly, for the post-implementation phase, we randomly selected 399 cases to review out of 752 total cases from March 1, 2006 to February 28, 2007. e 800 positive FOBT cases were then randomly assigned to one of the two chart reviewers, both of whom were sta primary care physicians (H.K., G.B.). We supervised and trained the reviewers during pilot testing to ensure comprehensive and standardized data collection. Chart reviews for this study were conducted between September 2007 and November 2007.
Chart review . e data collection form was designed to capture several scenarios following a positive FOBT result (see Figure 1 ) and was reviewed by multiple clinicians and pilot tested with the chart reviewers. Initially, charts were reviewed for evidence of colonoscopy referral or performance that may have taken prior to the positive FOBT; these were excluded. For the remaining cases, reviewers further examined the medical records for: (i) an evidence of follow-up actions by PCP and (ii) performance of a colonoscopy at some time following the FOBT up to the date the chart was reviewed. For determining the follow-up actions, reviewers documented four possible scenarios: (i) a colonoscopy referral was not indicated (e.g., documentation of patient refusal, documentation of colonoscopy being performed elsewhere, patient request for colonoscopy to be performed by a private physician), (ii) follow-up actions were determined to be inappropriate (ordering non-colonoscopy procedures such as barium enema or exible sigmoidoscopy, repeating FOBT), (iii) follow-up actions were 
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appropriate (ordering of colonoscopy or GI consult), or (iv) no follow-up actions were documented. Reviewers recorded whether the inappropriate actions such as non-colonoscopy tests resulted in an ultimate colonoscopy or not. For cases where colonoscopy was ordered (either directly or through a referral to GI service), reviewers determined whether it was successfully scheduled and if scheduled whether it was performed. If not performed, they determined whether the appointment was canceled by the GI service or by the patient (including a patient " no-show " ) and if colonoscopy was rescheduled and performed a er these situations. Times to PCP follow-up actions and colonoscopy performance were recorded. Although current guidelines at the time of our study did not explicitly state which patients should not undergo CRC screening with a colonoscopy (25 -27) , we used predened criteria ( Table 3 ) based on available literature (25,27 -30) to determine the appropriateness of screening colonoscopy. When providers missed the opportunity to take follow-up action on a positive FOBT, we determined the types of providers involved, and the types of visits involved (scheduled primary care follow-up visits vs. unscheduled drop-in visits).
Outcome measures . Because de nitions of appropriate followup vary greatly for cancer screening tests such as FOBT (1,6) , we used recommendations from a 2007 VA Directive to determine pre-and post-implementation outcomes (31) . is policy on CRC screening and follow-up timelines for VA facilities de nes timely referral for a colonoscopy to be within 14 days from an FOBT-positive report and timely colonoscopy performance as within 60 days from FOBT-positive report when a colonoscopy was indicated. e following outcome measures were calculated on eligible patients ( Figure 1 ), i.e., for whom a colonoscopy was indicated: Factors a ecting colonoscopy performance . In addition to the factors known to a ect colonoscopy performance such as patient non-adherence, we evaluated several factors that may lead to the non-performance of colonoscopy a er positive FOBT. ese included performance of a non-colonoscopy procedure such as barium enema or exible sigmoidoscopy, cancellation of colonoscopy procedure by GI, not agging consultation requests as urgent, PCPs not re-requesting consultations a er an initial cancellation by GI, and when GI service did not reschedule consultations a er an initial cancellation.
Data analysis
e reviewers entered the variables into a Microso Access database, and study personnel checked 10 % of cases to validate data entry. We used SAS (SAS Institute, Cary, NC, version 9.1) to conduct all statistical analyses. Cases who met inclusion criteria were divided into two groups: pre-and post-implementation of QI activities and baseline characteristics between the two were compared. We then compared provider responses to the FOBT noti cations (i.e., appropriate, inappropriate, no response) and the associated median duration between FOBT noti cation and response in the two groups. For the patients who met nal criteria for eligibility for colonoscopy (see Figure 1 ), we calculated and compared our ve outcome measures (see above) in the pre-and post-implementation groups. To evaluate factors in uencing the non-performance of colonoscopy, we rst used univariate analysis using chi-square and t-tests. Independent variables tested included performance of a non-colonoscopy procedure, patient nonadherence with colonoscopy appointment, cancellation of colonoscopy procedure appointment by GI, not agging consultation requests as urgent, PCPs not re-requesting consultations a er cancellation by GI, and lack of rescheduling by GI a er an initial cancellation. A multivariable logistic regression model was used in which the outcome variable was whether or not a patient had a colonoscopy performed, and predictors included variables with P < 0.1 in the univariate analyses. e model was t using maximum likelihood estimation, and odds ratios and 95 % con dence intervals were calculated.
RESULTS
To evaluate the e ectiveness of QI activities to improve the follow-up of FOBT results with colonoscopy, we reviewed records of 401 and 399 FOBT-positive patients, respectively, each from a 12-month period pre-and post-implementation (total n = 800). ere was no signi cant age di erence in the pre-and post-implementation groups (mean 64.8 and 63.3 years, respectively; P = 0.26). Race and gender distribution as well as the proportions of patients for whom colonoscopy was not found appropriate using predetermined criteria (speci ed in Table 3 ) were not signi cantly di erent in the two cohorts (see Table 1 ). Because colonoscopy referral or performance had taken place in 51 patients prior to the date of the positive FOBT, these patients were excluded from further analysis on follow-up actions. Table 2 shows follow-up actions and median times to follow-up action on the remaining 749 FOBT noti cations. In 112 (15 % ) cases, a follow-up action, i.e., colonoscopy referral was not needed because of patient refusal for further work-up, patient request to obtain it through a non-VA physician, patient report of the test having been performed elsewhere, or documented evidence of one or more prede ned exclusion criteria mentioned in Provider documented that patient was not a candidate for work-up (did not meet exclusion criteria listed in were further divided into appropriate, inappropriate, and no documented follow-up. Appropriate follow-up response was documented in 485 (76.1 % ) of these cases. Median times to appropriate follow-up was signi cantly shorter post-implementation (6 vs. 18 days, P < 0.0001). Inappropriate responses such as ordering a barium enema and repeating the FOBT occurred in 5.8 % of cases, whereas no evidence of follow-up actions was documented in 115 (18 % ) cases. Post-implementation, fewer positive FOBTs that were eligible for colonoscopy were followed by patient care visits that missed an opportunity to act on the abnormal nding (post ( n = 40; 7.5 % ) vs. pre ( n = 88; 16.5 % ), P < 0.0001). ese visits included scheduled visits with the PCP and any visit, scheduled or not, in which the FOBT results should have been viewed for complete assessment. As expected, most missed opportunities occurred in the primary care setting and involved sta physicians (64 % ), followed by physician assistants (26 % ), nurse practitioners (6 % ), and trainees (5 % ). e type of visit most commonly associated with missed opportunities were routine primary care follow-up visits (86 % ), followed by " drop-in " unscheduled patient visits (9 % ) and visits to other medical subspecialists (3 % ). ere was no signi cant di erence in these characteristics pre-and postimplementation.
Of 749 patients, we found 130 patients where colonoscopic screening for CRC was found to be not appropriate, given current guidelines and literature. In Table 3 , we describe their characteristics and outcomes. Just over 12 % (16 / 130) had already undergone a colonoscopy for the positive FOBT when we reviewed their records.
For calculation of our outcome measures, we only used patients who were eligible for colonoscopy, i.e., we excluded those where screening was either not appropriate or where colonoscopy was determined as not needed. is led to exclusion of 216 patients in total (some patients met both exclusion criteria; also see Figure 1 ). Hence, 533 patients met eligibility criteria for calculation of our outcome measures. e proportions of patients who received a timely colonoscopy referral and performance were signi cantly higher post-implementation (60.5 % vs. 31.7 % , P < 0.0001 and 11.4 % vs. 3.4 % , P = 0.0005). A signi cant decrease also resulted in median times to referral and performance post-implementation (6 vs. 19 days, P < 0.0001 and 96.5 vs. 190 days, P < 0.0001) and in the proportion of positive FOBT results with no follow-up by the time of chart review (24.3 % vs. 35.9 % ; P = 0.0045). Hence, all ve outcome variables showed favorable signi cant change post-implementation of the QI activities ( Table 4 ) .
In Table 5 , the results of several univariate analyses for factors potentially associated with colonoscopy performance (regardless of timely or not) in eligible patients is displayed. Signi cant factors associated with the lack of colonoscopy were performance of a non-colonoscopy procedure such as barium enema or exible sigmoidoscopy, patient non-adherence to a colonoscopy appointment, colonoscopy request marked as routine, i.e., not " urgent, " not providing an appropriate provisional a Potential exclusionary comorbidities included advanced chronic obstructive pulmonary disease with FEV1 < 30%, New York Heart Association class III or IV heart failure (symptoms of shortness of breath with daily activities or at rest); inoperable coronary artery disease; active malignancy being palliated or, if treatment with curative intent, less than 1 year in remission.
b Potential exclusionary reasons included documented report of a negative colonoscopy within the past 10 years, polyps removed in previous colonoscopy but not currently due for surveillance. scopy. Activities included improving the response of PCPs to abnormal FOBTs and tracking positive tests till colonoscopy performance. Although the timeliness of colonoscopy referral and performance was not optimal according to the recent VA policy recommendations, we found a signi cant increase in the proportion of patients who received a timely colonoscopy referral and a timely colonoscopy performance a er implementation of these activities. e QI activities were also accompanied by a signi cant decrease in the median times for colonoscopy referral and performance and a signi cant decrease in the proportion of FOBT results that were never followed-up. Prominent factors associated with a lack of performance of an indicated colonoscopy included patient non-adherence to scheduled colonoscopy appointments, and failure to re-request and reschedule canceled colonoscopy procedures. Because colonoscopy was not indicated in approximately one third of patients with positive FOBT (267 / 800), our study raises concerns about current screening practices and the appropriate denominator used for performance measurement standards related to CRC screening (32) . diagnosis on the consultation, GI service not rescheduling the colonoscopy procedure a er an initial cancellation, and PCPs not re-requesting colonoscopy a er a procedure was canceled by the gastroenterologist. In multivariable logistic regression model (data not shown in Table 5 ), we found that performance of a non-colonoscopy procedure such as barium enema or exible sigmoidoscopy (OR = 16.9; 95 % CI, 1.9 -145.1), patient non-adherence (OR = 33.9; 95 % CI, 17.3 -66.6), not providing an appropriate provisional diagnosis on the consultation (OR = 17.9; 95 % CI, 11.3-28.1) and GI service not rescheduling colonoscopies (OR = 11.0; 95 % CI, 5.1 -23.7) were signi cant predictors for lack of colonoscopy at chart review.
Among 271 patients who had a colonoscopy performed on chart review, we found 16 to have cancer, giving an overall yield of 5.9 % for colon cancer in our study population.
DISCUSSION
We studied the e ect of several QI activities to improve the follow-up of positive FOBT results with a timely colono- 
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Our study also has implications beyond the VA to many other health care systems that rely mostly on FOBT testing, rather than screening colonoscopies, due to limited colonoscopy capacity. Previous studies of activities to increase follow-up of abnormal cancer screens have mostly focused on patient-level factors and tests such as Papanicolaou smears (6,33 -36) . Relatively few studies have addressed systems-based practice and focused on providers, especially for FOBT follow-up (1, 6, 37) . For instance, a study by Myers et al . (37) provided physicians with reminders for abnormal FOBTs, accompanied by feedback on follow-up completion, educational visits, a tailored letter, and a follow-up reminder call. A study by Manfredi et al . (33) used procedures such as standardized communication from the exit nurse, a form that patients returned a er compliance, and written and telephone reminders to improve compliance with referrals for several abnormal screening tests including FOBT. However, none of these studies were conducted in systems with integrated EMRs, which potentially overcome test result noti cation barriers and facilitate tracking procedures.
Although we did not measure the impact of the individual components of the QI activities, we believe that provider notication (both through alerts and mailbox) followed by monitoring performed by the preventive medicine coordinator likely provided the greatest bene t in improving the FOBT followup. Despite the use of an integrated EMR and tracking patients until completion of the colonoscopy, the timely referral and performance rates for eligible patients improved to only about 60 % and 11 % , respectively. is inability to ensure subsequent follow-up in many cases is consistent with the results of previous interventions that have used tracking procedures (12) . Further performance improvement may result from activities not addressed by our initiatives, such as increasing capacity for colonoscopy procedures, improving care coordination processes that contribute to post-colonoscopy referral delays, and patient education. Overall timeliness of follow-up of positive FOBT remained far less than those recommended by recent VA policy recommendations (median duration of 96.5 days to colonoscopy performance post-implementation).
ese recommendations were released in early 2007, at the end of our study period, so their true impact on performance remains to be seen. Such QI activities highlight and accentuate the issue of limited endoscopic capacity, which is likely to worsen with further improvement in timely handling of positive FOBT results and clearing pending GI consults. Hence, these QI activities may paradoxically increase delays due to more referrals for colonoscopy and higher demand for this service. Despite these limitations, our activities resulted in improvement in provider response to abnormal test results; moreover, these initiatives are feasible and relatively easy to implement within systems that use integrated EMRs.
Although a recommendation or referral for colonoscopy was made in about 80 % of indicated cases, we found several inappropriate follow-up actions such as repeating the FOBT and ordering a barium enema or exible sigmoidoscopy. e frequency of these actions was much lower than that reported by Nadel et al . (38) in 2005, an e ect that could be partly explained by guideline di usion over time. Despite provider noti cation, about 15 % of positive FOBT cases lacked a documented follow-up plan at the time of chart review. Moreover, several opportunities to followup the test result occurred subsequent to the date of the FOBT when providers could have " caught " the abnormality in a readily accessible EMR system. Many of these missed opportunities involved visits during which a comprehensive patient assessment, including a review of test results, was indicated.
Our study ndings have implications for current and future policies and guidelines that address the timeliness or appropriateness of CRC screening. First, policy recommendations on timeliness, such as those released by the VA, must adopt benchmarks with explicit numerators and denominators in far more detail than currently done (31) . Currently, situations where colonoscopy for a positive FOBT is not indicated are not well accounted for and could result in signi cant underestimations of timeliness. Over 10% of positive FOBT cases in our study sample had a procedure performed elsewhere previously, a patient refusal, or a request for procedure performance elsewhere. Additionally, guidelines indicate that CRC screening is not required for up to 10 years following a negative colonoscopy but are silent on how to handle positive FOBTs in patients who have had a recent nagative colonoscopy (25, 39) . When we recalculated our outcome measures a er including the 31 patients with recent negative colonoscopy in the denominator, the rates were slightly lower because none of them had received a timely colonoscopy. Anecdotally, we have noticed a low yield for tests with recent negative colonoscopy. Currently in our system, most PCPs do not obtain FOBTs on patients who have had a recent negative colonoscopy. Given that the median time from FOBT result to colonoscopy performance was 96.5 days, our ndings also suggest a need for numerators that re ect achievable evidence-based practice goals; the 60-day colonoscopy performance recommendation may not be easily achievable currently without increased endoscopic capacity. When we used a 90-day time frame, the proportion of patients with timely performance was slightly better (post-implementation 27.3 % vs. pre-implementation 10.3 % ). Using a 120-day window, timely performance increased to 36.5 % post-QI vs. 16 % pre-QI. In a previous study, we found no di erence in outcomes (stage / survival) of patients with CRC diagnosed within 30, 60, or 90 days of positive FOBT (40) .
Second, during both pre-and post-implementation periods, we found that a large proportion of FOBTs ( ~ 17 % ) were performed on patients when the test was likely not indicated.
is problem has received heightened attention in recent literature (28, 30, 41) ; however, recently released guidelines do not adequately address who should not be screened for CRC (39) .
ese FOBTs further strain an already limited endoscopic capacity. Although only a small percentage of these patients (12.3 % ) ultimately underwent a colonoscopy in our study, the ndings call for more explicit appropriateness criteria to prevent the diversion of resources to patients who may the rates of timely colonoscopy referral and performance in an EMR system. Performance rates could be further improved by dedicated systems of care coordination and tracking to colonoscopy completion and possibly by improved colonoscopy capacity, requiring additional resource investment. Future patient-, provider-, and systems-based interventions are needed to improve timeliness of colonoscopy performance and patient adherence to diagnostic procedures.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 Fecal occult blood test (FOBT) is commonly used for colorectal cancer screening in several health-care settings.
3 Inadequate follow-up of FOBT results with a colonoscopy is common.
3 Patient-level, provider-level, or system-level factors may be responsible.
3 Relatively few studies address strategies to improve followup of abnormal cancer screens such as abnormal FOBTs.
WHAT IS NEW HERE
3 We report fi ndings before and after quality improvement initiatives to improve follow-up for abnormal FOBTs.
not necessarily need them. Such de ned exclusion parameters could link to electronic FOBT reminders in the medical record to guide providers and their patients to make informed choices. Notably, many of our exclusionary criteria were facility-speci c and not currently used in a standardized fashion nationwide to calculate VA performance measures.
Our study has implications not just for the VA but also for other health care institutions that use FOBT for screening due to limited colonoscopy capacity. ese institutions should consider implementing sophisticated EMR systems for improving follow-up of abnormal screen ndings (42) . In addition to improving electronic communication related to test results and consultations, further reduction in diagnostic delays (43) will also be possible with the advent of systems that are able to track colonoscopy completion post-referral. We believe that use of information technology and case managers with dedicated time could facilitate tracking procedures (44) . Consistent with previous studies (16, 45) , we found that patient adherence to colonoscopy was a signi cant barrier in getting a full colon evaluation. Previous interventions have focused on improving patient adherence to methods of cancer screening (46 -48) . However, interventions to improve patient adherence to follow-up procedures related to abnormal cancer screens are also warranted (19,33,37,49 -51) . Also needed are better systems of arranging follow-up procedures a er cancellations, a common scenario in ambulatory care practice. Whether the PCP re-requests a procedure or the gastroenterologist reschedules it on their own may depend on institutional practices, but this problem may be improved by better tracking systems (20,52 -54) using either reminders built into the EMR or navigation programs for patients with suspected cancer (19,55 -57) .
Our study has several strengths. Access and follow-up in the VA system is less a ected by nancial factors. In addition, the VA EMR allows for a comprehensive review of available data. Many previous studies (6, 11, 18, 38, 58, 59 ) have used either administrative data or patient self-reports to measure followup, but standardized medical chart review overcomes some of the limitations of these methods (60) .
Our results should be interpreted with several limitations. is was a single institution study and the ndings may not be generalizable to the study population of other VA facilities or to non-VA settings. Because of our retrospective chart review design, we were not able to determine precisely why providers did not follow-up on the FOBT results data, nor could we comprehensively examine the many other factors that may a ect timely colonoscopy performance. Although we were able to capture and account for many dual users of both VA and non-VA services through detailed chart review (61) , we may have missed some instances where information about colonoscopies in non-VA settings was not documented in the EMR. Additionally, due to resource limitations, our QI activities did not involve patient contact.
Conclusions
Multifaceted QI activities that focused on improving provider response to positive FOBT and reducing GI backlog improved
